-
Rescaled Tariff Regression for EQ-5D-5L Health State Valuation: An Equivalent Alternative to the Nonparametric Crosswalk
Sep 9, 2025, 16:22 PM -
Evaluating the Performance of an Artificial Intelligence A-Powered Tool for Assessing Quality of Published Economic Evaluations: A Comparison With Human Reviewers Using the Drummond Checklist
Sep 9, 2025, 16:22 PM -
Through a Glass Darkly: The What, How, and What Now for Global Net Price Transparency
Sep 9, 2025, 16:22 PM -
Funding the Fight Against Antimicrobial Resistance: Learnings From the UK and Sweden’s Pilot Incentive Programs
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Pegunigalsidase Alfa Compared to Agalsidase Alfa and Agalsidase Beta for the Treatment of Adult Patients With Fabry Disease in Greece
Sep 9, 2025, 16:22 PM -
Productivity Costs Due to Respiratory Infections in Denmark: A Potential for Prophylaxis
Sep 9, 2025, 16:22 PM -
Understanding the Impact of the NICE Severity Modifier: A Targeted Review of Oncology Submissions
Sep 9, 2025, 16:22 PM -
Patient Preference Studies in HTA for Rare Diseases: A Cross-Country Analysis of EU-4, UK, and Canada
Sep 9, 2025, 16:22 PM -
A Gap Analysis of HTA Methods in Europe: Results From SUSTAIN-HTA
Sep 9, 2025, 16:22 PM -
Can Adalimumab Serve as Big Mac Index for Pharmaceutical Prices?
Sep 9, 2025, 16:22 PM -
Comparison of Bispecific T-cell Engager Antibodies and CAR-T Therapies for Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma: A Systematic Review and Meta-Analysis
Sep 9, 2025, 16:22 PM -
Are Real-World Survival Outcomes in Metastatic Breast Cancer Transportable Between the US and Austria?
Sep 9, 2025, 16:22 PM -
Informing Value-Based Pricing: Cost-Effectiveness Analysis of a Hypothetical First-Line Therapy for Metastatic Pancreatic Cancer
Sep 9, 2025, 16:22 PM -
Developing Best Practice for Using Automation Tools in Literature Reviews
Sep 9, 2025, 16:22 PM -
The DM77 and Rare Diseases: Analysis of Regional Legislation in Italy
Sep 9, 2025, 16:22 PM -
The Cost of Inaction: Strengthening Nutrition in Frailty Guidelines Across Europe
Sep 9, 2025, 16:22 PM -
Evaluating the Economic Benefit of Improved High-Dose Influenza Vaccine Coverage in the Elderly Population of Tokyo, Japan
Sep 9, 2025, 16:22 PM -
Global Evaluation of Flexible Cysto-Nephroscope Usage Patterns in Percutaneous Nephrolithotomy Procedures
Sep 9, 2025, 16:22 PM -
A Comparison of Methods for Missing Covariates in a Meta-Regression Using Data From a Systematic Review on Oral Epithelial Dysplasia
Sep 9, 2025, 16:22 PM -
A Systematic Literature Review on Costs and Healthcare Resource Utilization in Spinal Muscular Atrophy
Sep 9, 2025, 16:22 PM
